Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Bolt Biotherapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$0.7

2024-10-29

Market Capitalization

$25.6 M

2024-10-29

Revenue

$7.9 M

FY, 2023

CreditSafe Score

?
Score changed on Feb 16, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2020FY, 2021FY, 2022FY, 2023
Revenue231.0K1.3M5.7M7.9M
General and administrative expense9.1M18.4M22.9M22.5M
Operating expense total49.4M94.0M96.1M
EBIT(49.2M)(92.8M)(90.3M)(76.2M)
EBIT margin, %-21290.9%-7364.1%-1576.6%
Investment income199.0K281.0K2.2M7.0M
Net Income(60.7M)(98.6M)(88.1M)(69.2M)
EPS(28.9)(3.0)(2.4)(1.0)

Footer menu